Read more
19:52 · 27 April 2026

Microsoft’s AI story enters a new phase. The market is watching Azure and earnings

Microsoft came under modest pressure today following reports of a restructuring in its relationship with OpenAI. The market quickly latched onto one detail that dominated the narrative: the company is expected to stop sharing a portion of its revenue with OpenAI. At first glance, this may appear to weaken the economic foundation of the partnership, but the reality is more nuanced.

This is not the end of the partnership, but rather its redefinition. The most important shift is not the revenue-sharing mechanism itself, but a change in the balance of power. OpenAI is gaining greater operational flexibility, with its technologies expected to be available beyond the Azure ecosystem. At the same time, Microsoft is losing part of the exclusivity that has been a key pillar of its AI narrative in recent years.

From a strategic perspective, the relationship remains important, but it is becoming less closed than before. Microsoft retains access to OpenAI’s core technologies and long-term rights to use them, yet the structure is evolving into a more market-driven and less asymmetric arrangement.

For investors, the key question is whether this change materially weakens the investment case for Microsoft. In the short term, the market may interpret it as a slight deterioration in Microsoft’s negotiating position vis-à-vis OpenAI, which helps explain today’s price reaction. Over a longer horizon, however, the removal of revenue-sharing obligations could improve the economics of the partnership, while Microsoft remains one of the primary beneficiaries of AI monetization through Azure and its Copilot suite.

Timing also matters. Microsoft is set to report quarterly earnings on Wednesday, placing this development squarely in the context of an upcoming catalyst. As a result, the market is not only digesting a shift in narrative but also preparing for hard data. In this environment, the earnings report is likely to carry more weight than the contractual details themselves.

Investors will be looking closely at Azure growth, the pace of AI adoption, and whether demand driven indirectly by OpenAI continues to translate into tangible performance in the cloud segment. In previous quarters, Microsoft has emphasized the measurable impact of its OpenAI partnership, both in accelerating Azure growth and in expanding commercial commitments tied to AI.

In that context, the latest development does not undermine Microsoft’s fundamentals as much as it reshapes the emphasis within its strategy. The company is not losing OpenAI, but it is giving up some degree of control over a relationship it helped build and that has been central to its growth narrative.

Ultimately, what matters more for the market than the structure of the agreement is whether Wednesday’s results confirm that Azure remains the core engine of Microsoft’s growth in the AI era. If that holds true, the evolving relationship with OpenAI may prove to be less of a risk and more of a natural step in the maturation of the broader AI ecosystem.

 
 

Source: xStation5
28 April 2026, 15:43

Alphabet Q1 Preview: High Bar and Pressure on Quality

28 April 2026, 14:20

Market Wrap: European banks under pressure, oil above $100

28 April 2026, 12:45

Novartis disappoints with its earnings, sending its stock down to a key support level 💥

27 April 2026, 20:51

Google targets military contracts. The market is waiting for earnings

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.